Adar Poonawalla's Serum Institute Gets Notice On Pausing Vaccine Trial | Read

PUBLISHED ON: September 9, 2020 | Duration: 1 min, 45 sec

  
loading..
The Serum Institute of India, which is manufacturing the Oxford University's Covishield vaccine and will hold the phase 3 clinical trials in India from next week, has been issued a showcause notice by the country's drug controller DGCI. Trials for the vaccine were stopped in four nations as a precautionary measure after one of the recipients in the UK showed some adverse symptoms, which are yet to be linked to the vaccine.
ALSO WATCH
The Biggest Stories Of December 02, 2020

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com